NICE rejects use of kidney cancer drugs | News | Nursing Times
Links shared publicly online about this topic.
- 1,795total visits
NICE rejects use of kidney cancer drugs | News | Nursing Times
NICE will not approve bevacizumab (Avastin), sorafenib (Nexavar) and temsirolimus to treat kidney cancer patients
View full resource at nursingtimes.net
Tags: Cancer, Cancer Medication, Kidney Cancer, Kidney Cancer Medication, Kidney Health, Urinary System, Drug, News
Most Recently Shared on August 26, 2009 at 11:38 am By:
News: NICE rejects use of kidney cancer drugs http://bit.ly/w0dSs
Advertisement
